What the research so far suggests The reason retatrutide is discussed so often in professional circles is that Phase 2 research has reported striking average weight-loss outcomes in controlled, monitored trial settings
Visit unifiedendocrinecare .com or reach out to our office to learn more about in-person visits in Fresno and Lafayette or California-wide telemedicine consultations
This conversation ensures supplementation aligns with your overall health strategy and doesn't inadvertently conflict with existing treatment goals
A consult lets us understand your metabolism, your hormone picture, your lifestyle, and any factors that would change what is safe and appropriate for you
The KD-chemotherapy group demonstrated an objective response rate (ORR) of 60% compared to 21% in controls, and a disease control rate (DCR) of 70% versus 64%
Unlike other weight loss injections, Retatrutide works by targeting three key hormone pathways rather than one or two, offering enhanced effectiveness
